Meta-analysis on the effect of the Ala54Thr polymorphism of the fatty acid-binding protein 2 gene on body mass index

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 10, 2011, Pages 823-829

  Zhao, T ^a   Zhao, J ^b   Lv, J ^a   Nzekebaloudou, M ^c  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Hangzhou Hospital of Traditional Chinese Medicine   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Body mass index; Fatty acid binding protein 2; Gene; Meta analysis; Polymorphism

Indexed keywords

FABP2 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN;

ARTICLE; BODY MASS; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; META ANALYSIS; OBESITY;

BODY MASS INDEX; FATTY ACID-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; MALE; OBESITY; POLYMORPHISM, GENETIC;

EID: 80053053692     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.02.020     Document Type: Article

References (41)

1. Roditis M.L., Parlapani E.S., Tzotzas T., Hassapidou M., Krassas G.E. Epidemiology and predisposing factors of obesity in Greece: from the Second World War until today. J Pediatr Endocrinol Metab 2009, 5:389-405.
2. Luo W., Morrison H., de Groh M., Waters C., DesMeules M., Jones-McLean E., et al. The burden of adult obesity in Canada. Chronic Dis Can 2007, 4:135-144.
3. Qi L., Cho Y.A. Gene-environment interaction and obesity. Nutr Rev 2008, 12:684-694.
4. Chakravarthy M.V., Zhu Y., Yin L., Coleman T., Pappan K.L., Marshall C.A., et al. Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation. J Lipid Res 2009, 4:630-640.
5. Yang W., Kelly T., He J. Genetic epidemiology of obesity. Epidemiol Rev 2007, 29:49-61.
6. Berthier M.T., Couillard C., Prudhomme D., Nadeau A., Bergeron J., Tremblay A., et al. Effects of the FABP2 A54T mutation on triglyceride metabolism of viscerally obese men. Obes Res 2001, 11:668-675.
7. Baier L.J., Sacchettini J.C., Knowler W.C., Eads J., Paolisso G., Tataranni P.A., et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995, 95:1281-1287.
8. de Luis D.A., Sagrado M.G., Aller R., Izaola O., Conde R. Influence of ALA54THR polymorphism of fatty acid-binding protein 2 on obesity and cardiovascular risk factors. Horm Metab Res 2007, 11:830-834.
9. Albala C., Santos J.L., Cifuentes M., Villarroel A.C., Lera L., Liberman C., et al. Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. Obes Res 2004, 2:340-345.
10. Deurenberg P., Deurenberg-Yap M., Guricci S. Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 2002, 3:141-146.
11. Fisher E., Li Y., Burwinkel B., Kühr V., Hoffmann K., Möhlig M., et al. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort. Horm Metab Res 2006, 5:341-345.
12. Nakanishi S., Yamane K., Kamei N., Okubo M., Kohno N. The effect of polymorphism in the intestinal fatty acid-binding protein 2 gene on fat metabolism is associated with gender and obesity amongst non-diabetic Japanese-Americans. Diabetes Obes Metab 2004, 1:45-49.
13. Albala C., Villarroel A., Santos J.L., Angel B., Lera L., Liberman C., et al. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders. Diabetes Res Clin Pract 2007, 2:245-250.
14. Galluzzi J.R., Cupples L.A., Otvos J.D., Wilson P.W., Schaefer E.J., Ordovas J.M. Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham Offspring Study. Atherosclerosis 2001, 2:417-424.
15. Brown M.D., Shuldiner A.R., Ferrell R.E., Weiss E.P., Korytkowski M.T., Zmuda J.M., et al. FABP2 genotype is associated with insulin sensitivity in older women. Metabolism 2001, 9:1102-1105.
16. Erkkila A.T., Lindi V., Lehto S., Pyorala K., Laakso M., Uusitupa M.I. Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease. Nutr Metab Cardiovasc Dis 2002, 2:53-59.
17. Tahvanainen E., Molin M., Vainio S., Tiret L., Nicaud V., Farinaro E., et al. Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants. Atherosclerosis 2000, 2:317-325.
18. Sipilainen R., Uusitupa M., Heikkinen S., Rissanen A., Laakso M. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J Clin Endocrinol Metab 1997, 8:2629-2632.
19. de Luis D.A., Sagrado M.G., Aller R., Izaola O., Conde R., Romero E. Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients. Obes Surg 2009, 12. [Epub ahead of print].
20. Lara-Castro C., Hunter G.R., Lovejoy J.C., Gower B.A., Fernández J.R. Association of the intestinal fatty acid-binding protein Ala54Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women. J Clin Endocrinol Metab 2005, 2:1196-1201.
21. Georgopoulos A., Aras O., Noutsou M., Tsai M.Y. Unlike type 2 diabetes, type 1 does not interact with the codon 54 polymorphism of the fatty acid binding protein 2 gene. J Clin Endocrinol Metab 2002, 8:3735-3739.
22. Georgopoulos A., Aras O., Tsai M.Y. Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab 2000, 85:3155-3160.
23. Oguri M., Kato K., Yokoi K., Itoh T., Yoshida T., Watanabe S., et al. Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome. Atherosclerosis 2009, 2:486-493.
24. Takakura Y., Yoshioka K., Umekawa T., Kogure A., Toda H., Yoshikawa T., et al. Thr54 allele of the FABP2 gene affects resting metabolic rate and visceral obesity. Diabetes Res Clin Pract 2005, 1:36-42.
25. Ishii T., Hirose H., Kawai T., Hayashi K., Maruyama H., Saito I., et al. Effects of intestinal fatty acid-binding protein gene Ala54Thr polymorphism and beta3-adrenergic receptor gene Trp64Arg polymorphism on insulin resistance and fasting plasma glucose in young to older Japanese men. Metabolism 2001, 11:301-307.
26. Kim C.H., Yun S.K., Byun D.W., Yoo M.H., Lee K.U., Suh K.I. Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia, but not with intestinal fatty acid absorption in Korean men. Metabolism 2001, 4:473-476.
27. Yamada K., Yuan X., Ishiyama S., Koyama K., Ichikawa F., Koyanagi A., et al. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 1997, 6:706-710.
28. Hayakawa T., Nagai Y., Nohara E., Yamashita H., Takamura T., Abe T., et al. Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects. Metabolism 1999, 5:655-657.
29. Ito K., Nakatani K., Fujii M., Katsuki A., Tsuchihashi K., Murata K., et al. Codon 54 polymorphism of the fatty acid binding protein gene and insulin resistance in the Japanese population. Diabet Med 1999, 2:119-124.
30. Xiang K.S., Zheng T.S., Jia W.P., Sun D.Q., Ding W., Li J., et al. The association of Ala54Thr variant of intestinal Fatty acid binding protein gene with general regional adipose tissue deposits. Chin Med Sci J 1999, 1:46-51.
31. Wang J., Si Q., Fu Y., Wang X.D. Polymorphism of the fatty acid-binding protein 2 gene in patients with coronary hear t disease. Int J Emerg and Crit Care Med 2006, 4:1352-1355.
32. Martinez-Lopez E., Ruíz-Madrigal B., Hernández-Canaveral I., Panduro A. Association of the T54 allele of the FABP2 gene with cardiovascular risk factors in obese Mexican subjects. Diab Vasc Dis Res 2007, 3:235-236.
33. Perez-Bravo F., Fuentes M., Angel B., Sanchez H., Carrasco E., Santos J.L., et al. Lack of association between the fatty acid binding protein 2 (FABP2) polymorphism with obesity and insulin resistance in two aboriginal populations from Chile. Acta Diabetol 2006, 4:93-98.
34. Vimaleswaran K.S., Radha V., Mohan V. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians. Metabolism 2006, 9:1222-1226.
35. Lei H.H., Coresh J., Shuldiner A.R., Boerwinkle E., Brancati F.L. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 1999, 9:1868-1872.
36. Attia J., Thakkinstian A., D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol 2003, 4:297-303.
37. Zintzaras E., Kitsios G., Stefanidis I. Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 2006, 4:700-710.
38. Zintzaras E., Chatzoulis D.Z., Karabatsas C.H., Stefanidis I. The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet 2005, 6:267-275.
39. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simples, graphical test. BMJ 1997, 315:629-634.
40. Bax L., Yu L.M., Ikeda N., Tsuruta H., Moons K.G.M. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006, 6:50.
41. Bax L., Yu L.M., Ikeda N., Tsuruta H., Moons K.G.M. MIX: comprehensive free software for meta-analysis of causal research data. Version 1.7 http://mix-for-meta-analysis.info.